Literature DB >> 6698636

Age at first birth and breast atypia.

C C Hsieh, A M Walker, E J Trapido, A W Crosson, B MacMahon.   

Abstract

The relation between age at first birth and the occurrence of fibrocystic breast disease of different atypia subtypes was evaluated using data from a cohort study of the health effects of oral-contraceptive use. Multivariate case-control analysis was performed on 218 parous women with biopsied fibrocystic disease and 928 parous controls. Fibrocystic breast disease, as a whole and as atypia subtypes, was found to be unrelated to age at first birth. Furthermore, the estimated effect of age at first birth did not vary from one atypia subtype to another. Women with high parity were found to be at decreased risk of fibrocystic breast disease compared to those with low parity. Age at completion of education, used as an indicator of socioeconomic status, was found to be moderately associated with fibrocystic breast disease. The estimated effect of parity and age at completion of education also did not vary among subtypes. More epidemiologic studies specific to histopathologic classifications of benign breast disease are called for.

Entities:  

Mesh:

Year:  1984        PMID: 6698636     DOI: 10.1002/ijc.2910330306

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Atypical hyperplasia and breast cancer risk: a critique.

Authors:  L Ma; N F Boyd
Journal:  Cancer Causes Control       Date:  1992-11       Impact factor: 2.506

2.  Relationship Between Proliferative Breast Lesions and Breast Cancer Risk Factors.

Authors:  Osman Toktaş; Sadi Elasan; Ümit Haluk İliklerden; Remzi Erten; Ali Rıza Karayil; Abdulselam Özdemir; Fırat Aslan; Serhat Binici; İbrahim Özalp; Enes Şentürk
Journal:  Eur J Breast Health       Date:  2020-12-24

3.  Parity factors and prevalence of fibrocystic breast change in a forensic autopsy series.

Authors:  D R Pathak; M C Pike; C R Key; S R Teaf; S A Bartow
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.